Particularly, among circadian genes, ARNTL2, a core component of the circadian clock, has been demonstrated as a potent oncogene that facilitates various tumor invasiveness and metastasis via diverse molecular mechanisms. The gene discussed is BMAL2; the disease is neoplasm.